Skip to main content
Log in

Factor VIII and coronary heart disease

  • Haemostatic function and cardiovascular disease
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

In plasma, Factor VIII is bound to its carrier protein, von Willebrand Factor (vWF). Therefore, the levels of these two factors vary together. From studies in the general population, in patients with coronary heart disease and in hemophilia patients, an association between Factor VIII levels and coronary heart disease clearly emerges.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. AronsonD.L. (1988): Cause of death in hemophilia A patients in the United States from 1968 to 1979 - Am. J. Hematol,27: 7–12.

    Google Scholar 

  2. BalleisenL.,SchulteH.,AssmannG.,EppingP.H. andLooJ.van de (1987): Coagulation factors and the progress of coronary heart disease - Lancetii: 461.

    Google Scholar 

  3. CucuianuM.P.,CristeaA.,RomanS.,RusH.,MissitsI. andPechetL. (1983): Comparative behaviour of the components of the factor VIII complex in acute myocardial infarction - Tromb. Res.30: 487–497.

    Google Scholar 

  4. DaviesM.J. andThomasA. (1984): Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death - N. Engl. J. Med.310: 1137–1140.

    Google Scholar 

  5. DeWoodM.A.,SporesJ.,NotskeR.,MouserL.T.,BurroughsR.,GoldenM.S. andLangH.T. (1980): Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction - N. Engl. J. Med.303: 897–902.

    Google Scholar 

  6. FusterY.,BowieE.J.W.,LewisJ.C.,FassD.N.,OwenC.A. andBrownA.L. (1978): Resistance to arteriosclerosis in pigs with von Willebrand's disease- J. Clin. Invest.61: 722–730.

    Google Scholar 

  7. HainesA.P.,HowarthD.,NorthW.R.S.,GoldenbergE.,StirlingY.,MeadeT.W.,RafteryE.B. andMillar CraigM.W. (1983): Haemostatic variables and the outcome of myocardial infarction - Thromb. Haemost.50: 800–803.

    Google Scholar 

  8. KannelW.B.,D' AgostinoR.B. andBelangerA.J. (1987): Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study - Am. Heart. J.113: 1006–1010.

    Google Scholar 

  9. KingsburyK.J. (1971): Relation of ABO blood-groups to atheroclerosis. - Lanceti: 199–203.

    Google Scholar 

  10. LarssonS.A. andWiechelB. (1983): Deaths in Swedish hemophiliacs, 1957–1980 - Acta Med. Scand.214: 199–206.

    Google Scholar 

  11. MeadeT.W. (1987): Epidemiology of atheroma, thrombosis and ischaemic heart disease. In: Haemostasis and Thrombosis (pp 697–720). Bloom A.L., Thomas D.P. (eds). Churchill Livingstone. Edinburgh.

    Google Scholar 

  12. MeadeT.W.,MellowsS.,BrozovicM.,MillerG.J.,ChakrabartiR.R.,NorthW.R.S.,HainesA.P.,StirlingY.,ImesonJ.D. andThompsonS.G. (1986): Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study -Lancetii: 533–537.

    Google Scholar 

  13. MedalieJ.H.,LeveneC.,PapierC.,GoldbourtU.,DreyfussF.,OronD.,NeufeldH. andRissE. (1981): Blood groups, myocardial infarction and angina pectoris among 10,000 adult males - N. Engl. J. Med.285: 1348–1353.

    Google Scholar 

  14. O'BrienJ.R. (1990): Blood group, von Willebrand's factor and heart disease - Thromb. Res.59: 221.

    Google Scholar 

  15. RizzaC.R. andSpoonerR.J.D. (1983): Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976–1980: report on behalf of the directors of haemophilia centres in the United Kingdom - Br. Med. J.286: 929–933.

    Google Scholar 

  16. RosendaalF.R.,BrietE.,StibbeJ.,HerpenG.van.Gevers LeuvenJ.A.,HofmanA. andVandenbrouckeJ.P. (1990): Haemophilia protects against ischaemic heart disease: a study of risk factors - Br. J. Haematol.75: 525–530.

    Google Scholar 

  17. RosendaalF.R.,SmitE. andBriëtE. (1991): Hemophilia treatment in historical perspective: a review of medical and social developments - Ann. Hematol.62: 5–15.

    Google Scholar 

  18. RosendaalF.R.,YarekampI.,SmitC.,Bröcker-YriendsA.H.J.T,DijckH.van,YandenbrouckeJ.P.,HermansJ.,SuurmeijerT.P.B.M. andBriëtE. (1989): Mortality and causes of death in Dutch haemophiliacs 1973–1986 -Br. J. Haematol.71: 71–76.

    Google Scholar 

  19. SchillerW.G.,HartmannG. andRemdeW. (1985): Todesursachen von Hdmophiliepatienten in der DDR - Folia Haematol. (Leipzig)112: 845–852.

    Google Scholar 

  20. Sixty Plus Reinfarction Study Research Group (1980): A double-blind trial to assess long-term anticoagulant therapy in elderly patients after myocardial infarction: report from the Sixty Plus Reinfarction Study Research Group - Lancetii: 989–994.

    Google Scholar 

  21. SmithP.,ArnesenH. andHolmeI. (1990): The effect of warfarin on mortality and reinfarction after myocardial infarction - N. Engl. J. Med.323: 147–152.

    Google Scholar 

  22. WhincupP.H.,PhillipsA.N.ShaperA.G. (1990): ABO blood groups and ischaemic heart disease in British men - Br. Med. J.300: 1679–1682.

    Google Scholar 

  23. WilhelmsenL.,SvärsuddK.,Korsan-BengstenK.,LarssonB.,WelinL. andTibblinG. (1984): Fibrinogen as a risk factor for stroke and myocardial infarction - N. Engl. J. Med.311: 501–505.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosendaal, F.R. Factor VIII and coronary heart disease. Eur J Epidemiol 8 (Suppl 1), 71–75 (1992). https://doi.org/10.1007/BF00145353

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00145353

Key words

Navigation